Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Not Yet Recruiting

The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma

NCT07386002

Conditions: Disease Attributes, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Pathologic Processes, +2 more
Locations: The Johns Hopkins Sidney Kimmel Cancer Center Baltimore, Maryland, United States

Hualien Tzu Chi Hospital Hualien City, Taiwan

Chang Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan

Chang Gung Memorial Hospital, Linkou Taoyuan, Taiwan

View Trial Details

Not Yet Recruiting

Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lymphomas

NCT07387848

Conditions: Diffuse Large B Cell Lymphoma Refractory, Disease Attributes, Pathologic Processes, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma

NCT07379489

Conditions: Adjuvant Therapy, Disease Attributes, HCC, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF) for Newly Diagnosed and Recurrent Ovarian Cancer

NCT07286162

Conditions: Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +18 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Not Yet Recruiting

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

NCT07363330

Conditions: Cervical Cancer, Disease Attributes, Female Urogenital Diseases, +19 more
Locations: Zhongnan Hospital of Wuhan University Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence

NCT07361666

Conditions: Basal Cell Carcinoma (BCC), Basal Cell Carcinoma of Skin, Basal Cell Carcinoma of the Head and Neck, +22 more
Locations: National Medical Institute of the Ministry of the Interior and Administration in Warsaw Warsaw, Masovian Voivodeship, Poland

View Trial Details

Not Yet Recruiting

Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC

NCT07350824

Conditions: Disease Attributes, HCC, Minimal Residual Disease, +6 more
Locations: Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT07345741

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, China

View Trial Details

Not Yet Recruiting

A Phase 2, Single Arm Multicenter, Study Testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT07348393

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Saint-Antoine Hospital Paris, France

View Trial Details

Not Yet Recruiting

Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk

NCT07347977

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: The first affiliated hospital of Ningbo University Ningbo, Zhejiang, China

View Trial Details

Recurrence

Recurrence trial results

Related conditions